Commentary
Should combination therapy with inhaled corticosteroids and long-acting β2-agonists be prescribed as initial maintenance treatment for asthma?
Catherine Lemière, Allan Becker, Louis-Philippe Boulet, Dennis Bowie, André Cartier, Donald Cockroft, Robert Cowie, Pierre Ernst, Mark Fitzgerald, Malcolm Sears, Sheldon Spier and The Asthma Committee of the Canadian Thoracic Society
CMAJ October 29, 2002 167 (9) 1008-1009;
Catherine Lemière
From the Service de pneumologie, Université de Montréal, Montreal, Que. (C.L., A.C.); the Health Sciences Center, University of Manitoba, Winnipeg, Man. (A.B.); the Service de pneumologie, Université Laval, Sainte Foy, Que. (L.P.B.); the Division of Respirology, Dalhousie University, Halifax, NS (D.B.); the Division of Respiratory Medicine, University of Saskatchewan, Saskatoon, Sask. (D.C.); the Health Sciences Center (R.C.) and the Division of Pediatric Respiratory Medicine, University of Calgary, Calgary, Alta. (S.S.); the Division of Clinical Epidemiology, McGill University, Montreal, Que. (P.E.); the Center for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver, BC (M.F.); and the Firestone Regional Chest and Allergy Unit, McMaster University, Hamilton, Ont. (M.S.).
Allan Becker
From the Service de pneumologie, Université de Montréal, Montreal, Que. (C.L., A.C.); the Health Sciences Center, University of Manitoba, Winnipeg, Man. (A.B.); the Service de pneumologie, Université Laval, Sainte Foy, Que. (L.P.B.); the Division of Respirology, Dalhousie University, Halifax, NS (D.B.); the Division of Respiratory Medicine, University of Saskatchewan, Saskatoon, Sask. (D.C.); the Health Sciences Center (R.C.) and the Division of Pediatric Respiratory Medicine, University of Calgary, Calgary, Alta. (S.S.); the Division of Clinical Epidemiology, McGill University, Montreal, Que. (P.E.); the Center for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver, BC (M.F.); and the Firestone Regional Chest and Allergy Unit, McMaster University, Hamilton, Ont. (M.S.).
Louis-Philippe Boulet
From the Service de pneumologie, Université de Montréal, Montreal, Que. (C.L., A.C.); the Health Sciences Center, University of Manitoba, Winnipeg, Man. (A.B.); the Service de pneumologie, Université Laval, Sainte Foy, Que. (L.P.B.); the Division of Respirology, Dalhousie University, Halifax, NS (D.B.); the Division of Respiratory Medicine, University of Saskatchewan, Saskatoon, Sask. (D.C.); the Health Sciences Center (R.C.) and the Division of Pediatric Respiratory Medicine, University of Calgary, Calgary, Alta. (S.S.); the Division of Clinical Epidemiology, McGill University, Montreal, Que. (P.E.); the Center for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver, BC (M.F.); and the Firestone Regional Chest and Allergy Unit, McMaster University, Hamilton, Ont. (M.S.).
Dennis Bowie
From the Service de pneumologie, Université de Montréal, Montreal, Que. (C.L., A.C.); the Health Sciences Center, University of Manitoba, Winnipeg, Man. (A.B.); the Service de pneumologie, Université Laval, Sainte Foy, Que. (L.P.B.); the Division of Respirology, Dalhousie University, Halifax, NS (D.B.); the Division of Respiratory Medicine, University of Saskatchewan, Saskatoon, Sask. (D.C.); the Health Sciences Center (R.C.) and the Division of Pediatric Respiratory Medicine, University of Calgary, Calgary, Alta. (S.S.); the Division of Clinical Epidemiology, McGill University, Montreal, Que. (P.E.); the Center for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver, BC (M.F.); and the Firestone Regional Chest and Allergy Unit, McMaster University, Hamilton, Ont. (M.S.).
André Cartier
From the Service de pneumologie, Université de Montréal, Montreal, Que. (C.L., A.C.); the Health Sciences Center, University of Manitoba, Winnipeg, Man. (A.B.); the Service de pneumologie, Université Laval, Sainte Foy, Que. (L.P.B.); the Division of Respirology, Dalhousie University, Halifax, NS (D.B.); the Division of Respiratory Medicine, University of Saskatchewan, Saskatoon, Sask. (D.C.); the Health Sciences Center (R.C.) and the Division of Pediatric Respiratory Medicine, University of Calgary, Calgary, Alta. (S.S.); the Division of Clinical Epidemiology, McGill University, Montreal, Que. (P.E.); the Center for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver, BC (M.F.); and the Firestone Regional Chest and Allergy Unit, McMaster University, Hamilton, Ont. (M.S.).
Donald Cockroft
From the Service de pneumologie, Université de Montréal, Montreal, Que. (C.L., A.C.); the Health Sciences Center, University of Manitoba, Winnipeg, Man. (A.B.); the Service de pneumologie, Université Laval, Sainte Foy, Que. (L.P.B.); the Division of Respirology, Dalhousie University, Halifax, NS (D.B.); the Division of Respiratory Medicine, University of Saskatchewan, Saskatoon, Sask. (D.C.); the Health Sciences Center (R.C.) and the Division of Pediatric Respiratory Medicine, University of Calgary, Calgary, Alta. (S.S.); the Division of Clinical Epidemiology, McGill University, Montreal, Que. (P.E.); the Center for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver, BC (M.F.); and the Firestone Regional Chest and Allergy Unit, McMaster University, Hamilton, Ont. (M.S.).
Robert Cowie
From the Service de pneumologie, Université de Montréal, Montreal, Que. (C.L., A.C.); the Health Sciences Center, University of Manitoba, Winnipeg, Man. (A.B.); the Service de pneumologie, Université Laval, Sainte Foy, Que. (L.P.B.); the Division of Respirology, Dalhousie University, Halifax, NS (D.B.); the Division of Respiratory Medicine, University of Saskatchewan, Saskatoon, Sask. (D.C.); the Health Sciences Center (R.C.) and the Division of Pediatric Respiratory Medicine, University of Calgary, Calgary, Alta. (S.S.); the Division of Clinical Epidemiology, McGill University, Montreal, Que. (P.E.); the Center for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver, BC (M.F.); and the Firestone Regional Chest and Allergy Unit, McMaster University, Hamilton, Ont. (M.S.).
Pierre Ernst
From the Service de pneumologie, Université de Montréal, Montreal, Que. (C.L., A.C.); the Health Sciences Center, University of Manitoba, Winnipeg, Man. (A.B.); the Service de pneumologie, Université Laval, Sainte Foy, Que. (L.P.B.); the Division of Respirology, Dalhousie University, Halifax, NS (D.B.); the Division of Respiratory Medicine, University of Saskatchewan, Saskatoon, Sask. (D.C.); the Health Sciences Center (R.C.) and the Division of Pediatric Respiratory Medicine, University of Calgary, Calgary, Alta. (S.S.); the Division of Clinical Epidemiology, McGill University, Montreal, Que. (P.E.); the Center for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver, BC (M.F.); and the Firestone Regional Chest and Allergy Unit, McMaster University, Hamilton, Ont. (M.S.).
Mark Fitzgerald
From the Service de pneumologie, Université de Montréal, Montreal, Que. (C.L., A.C.); the Health Sciences Center, University of Manitoba, Winnipeg, Man. (A.B.); the Service de pneumologie, Université Laval, Sainte Foy, Que. (L.P.B.); the Division of Respirology, Dalhousie University, Halifax, NS (D.B.); the Division of Respiratory Medicine, University of Saskatchewan, Saskatoon, Sask. (D.C.); the Health Sciences Center (R.C.) and the Division of Pediatric Respiratory Medicine, University of Calgary, Calgary, Alta. (S.S.); the Division of Clinical Epidemiology, McGill University, Montreal, Que. (P.E.); the Center for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver, BC (M.F.); and the Firestone Regional Chest and Allergy Unit, McMaster University, Hamilton, Ont. (M.S.).
Malcolm Sears
From the Service de pneumologie, Université de Montréal, Montreal, Que. (C.L., A.C.); the Health Sciences Center, University of Manitoba, Winnipeg, Man. (A.B.); the Service de pneumologie, Université Laval, Sainte Foy, Que. (L.P.B.); the Division of Respirology, Dalhousie University, Halifax, NS (D.B.); the Division of Respiratory Medicine, University of Saskatchewan, Saskatoon, Sask. (D.C.); the Health Sciences Center (R.C.) and the Division of Pediatric Respiratory Medicine, University of Calgary, Calgary, Alta. (S.S.); the Division of Clinical Epidemiology, McGill University, Montreal, Que. (P.E.); the Center for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver, BC (M.F.); and the Firestone Regional Chest and Allergy Unit, McMaster University, Hamilton, Ont. (M.S.).
Sheldon Spier
From the Service de pneumologie, Université de Montréal, Montreal, Que. (C.L., A.C.); the Health Sciences Center, University of Manitoba, Winnipeg, Man. (A.B.); the Service de pneumologie, Université Laval, Sainte Foy, Que. (L.P.B.); the Division of Respirology, Dalhousie University, Halifax, NS (D.B.); the Division of Respiratory Medicine, University of Saskatchewan, Saskatoon, Sask. (D.C.); the Health Sciences Center (R.C.) and the Division of Pediatric Respiratory Medicine, University of Calgary, Calgary, Alta. (S.S.); the Division of Clinical Epidemiology, McGill University, Montreal, Que. (P.E.); the Center for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver, BC (M.F.); and the Firestone Regional Chest and Allergy Unit, McMaster University, Hamilton, Ont. (M.S.).
From the Service de pneumologie, Université de Montréal, Montreal, Que. (C.L., A.C.); the Health Sciences Center, University of Manitoba, Winnipeg, Man. (A.B.); the Service de pneumologie, Université Laval, Sainte Foy, Que. (L.P.B.); the Division of Respirology, Dalhousie University, Halifax, NS (D.B.); the Division of Respiratory Medicine, University of Saskatchewan, Saskatoon, Sask. (D.C.); the Health Sciences Center (R.C.) and the Division of Pediatric Respiratory Medicine, University of Calgary, Calgary, Alta. (S.S.); the Division of Clinical Epidemiology, McGill University, Montreal, Que. (P.E.); the Center for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver, BC (M.F.); and the Firestone Regional Chest and Allergy Unit, McMaster University, Hamilton, Ont. (M.S.).
Article Information
vol. 167 no. 9 1008-1009
Author Information
- Catherine Lemière,
- Allan Becker,
- Louis-Philippe Boulet,
- Dennis Bowie,
- André Cartier,
- Donald Cockroft,
- Robert Cowie,
- Pierre Ernst,
- Mark Fitzgerald,
- Malcolm Sears,
- Sheldon Spier,
- The Asthma Committee of the Canadian Thoracic Society
- From the Service de pneumologie, Université de Montréal, Montreal, Que. (C.L., A.C.); the Health Sciences Center, University of Manitoba, Winnipeg, Man. (A.B.); the Service de pneumologie, Université Laval, Sainte Foy, Que. (L.P.B.); the Division of Respirology, Dalhousie University, Halifax, NS (D.B.); the Division of Respiratory Medicine, University of Saskatchewan, Saskatoon, Sask. (D.C.); the Health Sciences Center (R.C.) and the Division of Pediatric Respiratory Medicine, University of Calgary, Calgary, Alta. (S.S.); the Division of Clinical Epidemiology, McGill University, Montreal, Que. (P.E.); the Center for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver, BC (M.F.); and the Firestone Regional Chest and Allergy Unit, McMaster University, Hamilton, Ont. (M.S.).
- Correspondence to:
Dr. Catherine Lemière, Service de pneumologie, Hôpital du Sacré-Coeur, 5400 West Gouin, Montreal QC H4J 1C5; fax 514 338 3123; lemierec{at}crhsc.umontreal.ca
Statistics from Altmetric.com
In this issue
Article tools
Respond to this article
Should combination therapy with inhaled corticosteroids and long-acting β2-agonists be prescribed as initial maintenance treatment for asthma?
Catherine Lemière, Allan Becker, Louis-Philippe Boulet, Dennis Bowie, André Cartier, Donald Cockroft, Robert Cowie, Pierre Ernst, Mark Fitzgerald, Malcolm Sears, Sheldon Spier, The Asthma Committee of the Canadian Thoracic Society
CMAJ Oct 2002, 167 (9) 1008-1009;
Should combination therapy with inhaled corticosteroids and long-acting β2-agonists be prescribed as initial maintenance treatment for asthma?
Catherine Lemière, Allan Becker, Louis-Philippe Boulet, Dennis Bowie, André Cartier, Donald Cockroft, Robert Cowie, Pierre Ernst, Mark Fitzgerald, Malcolm Sears, Sheldon Spier, The Asthma Committee of the Canadian Thoracic Society
CMAJ Oct 2002, 167 (9) 1008-1009;